Pancreatic cancer: diagnosis and treatments (Q38354856)

2 September 2017

1 reference

title

Pancreatic cancer: diagnosis and treatments (English)

1 reference

2 September 2017

1 reference

1 reference

Hong-Yu Li

1

1 reference

2 September 2017

Zhong-Min Cui

2

1 reference

2 September 2017

Jiang Chen

3

1 reference

2 September 2017

Xiao-Zhong Guo

4

1 reference

2 September 2017

Ying-Yi Li

5

1 reference

2 September 2017

14 February 2015

1 reference

2 September 2017

1 reference

2 September 2017

36

1 reference

2 September 2017

3

1 reference

2 September 2017

1375-1384

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3223-7

2 September 2017

0 references

cites work

The accuracy of cancer mortality statistics based on death certificates in the United States.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Comparison between multislice CT and MR imaging in the diagnostic evaluation of patients with pancreatic masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Staging of pancreatic adenocarcinoma by imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Sildenafil-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Radiology of pancreatic adenocarcinoma: current status of imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Magnetic resonance cholangiopancreatography: image quality, ductal morphology, and value of additional T2- and T1-weighted sequences for the assessment of suspected pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

EUS/EUS-FNA for suspected pancreatic cancer: influence of chronic pancreatitis and clinical presentation with or without obstructive jaundice on performance characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

EUS-guided FNA of solid pancreas tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Technical Advances in Endoscopic Ultrasound (EUS)-Guided Tissue Acquisition for Pancreatic Cancers: How Can We Get the Best Results with EUS-Guided Fine Needle Aspiration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration for solid pancreatic lesion: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

PET/CT of cancer patients: part 1, pancreatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Pancreatic cancer: FDG-PET is not useful in early pancreatic cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

CA 242 is a new tumor marker for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Discovery of novel tumor markers of pancreatic cancer using global gene expression technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Diagnostic significance of serum osteopontin level for pancreatic cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Recent progress in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

The neuronal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Telomerase as a new target for pancreatic cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Modified standard pancreaticoduodenectomy for the treatment of pancreatic head cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Pancreaticoduodenectomy for pancreatic cancer: the Verona experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Distal pancreatectomy with celiac axis resection for carcinoma of the body and tail of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Total pancreatectomy: indications, operative technique, and results: a single centre experience and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Randomized phase II comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Randomized phase III trial of gemcitabine plus cisplatin compared with gemcitabine alone in advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Analgesic effect of high intensity focused ultrasound therapy for unresectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

EGFR and cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Phase II study of nimotuzumab, a humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients with locally advanced or metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

The ABCC4 gene is a promising target for pancreatic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Monoclonal antibody therapies targeting pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Risk Factors for Post-ERCP Cholangitis in Patients with Pancreatic Cancer from a Single Referral Center in Iran

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3223-7

Treatment of resectable and locally advanced pancreatic cancer

21 January 2018

1 reference

12 December 2020

Tissue sampling at ERCP in suspected pancreatic cancer

1 reference

12 December 2020

Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas

1 reference

12 December 2020

The growth inhibitory effects by transfection of p16 gene on human pancreatic cancer cell line

1 reference

12 December 2020

Pancreaticoduodenectomy for invasive pancreatic cancer (with video)

1 reference

12 December 2020

Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial

1 reference

12 December 2020

[A case of pancreatic solid-pseudopapillary tumor without cystic component in an elderly man]

1 reference

12 December 2020

Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

1 reference

12 December 2020

CA125 is superior to CA19-9 in predicting the resectability of pancreatic cancer

1 reference

12 December 2020

Standard whipple's operation versus pylorus preserving pancreaticoduodenectomy: a randomized controlled trial study

1 reference

12 December 2020

Erlotinib plus gemcitabine combination therapy in patients with unresectable advanced pancreatic cancer - a single-institution experience

1 reference

12 December 2020

Radical antegrade modular pancreatosplenectomy procedure for adenocarcinoma of the body and tail of the pancreas: ability to obtain negative tangential margins

1 reference

12 December 2020

Pancreatic adenocarcinoma

1 reference

12 December 2020

Risk factors for post-ERCP cholangitis in patients with pancreatic cancer from a single referral center in Iran

1 reference

12 December 2020

[Dosimetric comparison of treatment plans of pancreatic carcinoma treated with body gamma knife and tomotherapy].

1 reference

12 December 2020

SELDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of a boosting decision tree model for diagnosis of pancreatic cancer.

1 reference

12 December 2020

Imaging of small pancreatic ductal adenocarcinoma.

1 reference

12 December 2020

Current developments, problems and solutions in the non-surgical treatment of pancreatic cancer

1 reference

12 December 2020

A novel arterial infusion chemotherapy for the treatment of patients with advanced pancreatic carcinoma after vascular supply distribution via superselective embolization

1 reference

12 December 2020

Serum CA19-9 determination in the management of pancreatic cancer

1 reference

12 December 2020

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

12 December 2020

10.1007/S13277-015-3223-7

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

1037794994

0 references

Fatcat ID

release_u6yqpppiizevvgxcnq7szmjmma

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/u6yqpppiizevvgxcnq7szmjmma

24 November 2022

mapped directly with Wikidata item

1 reference